首页> 外文期刊>Clinical Immunology, Endocrine & Metabolic Drugs >Recent Advances in Clinical Immunology, Endocrine & Metabolic Drugs: An Editorial Overview
【24h】

Recent Advances in Clinical Immunology, Endocrine & Metabolic Drugs: An Editorial Overview

机译:临床免疫学,内分泌和代谢药物的最新进展:编辑概述

获取原文
获取原文并翻译 | 示例
           

摘要

An analytical review of the articles published in the two issues of Clinical Immunology Endocrine Metabolic Drugs (volume 1, 2014) is reported. Various topics are covered in volume 1 of the journal. Clinical Immunology is represented in six articles related to nickel hypersensitivity (2 articles), therapeutic approaches in human tuberculosis, immune biomarkers in trauma patients, salivary cytokines in normal weight children and oral sensiti-zation in rats. Endocrinology is the main topic of the two articles dealing with polycystic ovary syndrome and androgen receptor antagonists in prostate cancer. The vascular pathophysiology is the major theme of two papers dealing with the role of angiotensin II and post-prandial oxidative burst. Finally, a paper is devoted to antibiotics resistance of four probiotics.
机译:报告对两期《临床免疫内分泌代谢药物》(2014年第1卷)中发表的文章进行了分析性综述。该期刊的第1卷涵盖了各种主题。临床免疫学涉及六篇与镍过敏相关的文章(两篇文章),人类结核病的治疗方法,创伤患者的免疫生物标志物,正常体重儿童的唾液细胞因子和大鼠的口腔致敏作用。内分泌学是涉及前列腺癌多囊卵巢综合征和雄激素受体拮抗剂的两篇文章的主题。血管病理生理学是涉及血管紧张素II和餐后氧化爆发的两篇论文的主题。最后,一篇论文专门介绍了四种益生菌的抗药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号